{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-25-002897","form_type":"8-K","ticker":"VNRX","cik":"0000093314","company_name":"VOLITIONRX LTD","filed_at":"2025-04-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.875762+00:00","generated_at":"2026-05-23T09:55:38.904251+00:00","sec_items":["1.01","1.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"VolitionRx enters up to $7.5M at-the-market stock offering agreement with JonesTrading","bullets":["New 'Capital on Demand' sales agreement with JonesTrading allows sale of up to $7.5M common stock via ATM.","Sales agent commission 3% of gross proceeds; company not obligated to sell any shares.","Replaces prior $25M ATM program with Jefferies, terminated effective April 20, 2025.","Proceeds intended for R&D, product development, clinical studies, commercialization, working capital, and potential acquisitions."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-25-002897","json":"https://secwatch.observer/filing/0001477932-25-002897.json","markdown":"https://secwatch.observer/filing/0001477932-25-002897.md","text":"https://secwatch.observer/filing/0001477932-25-002897.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/93314/000147793225002897/0001477932-25-002897-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/93314/000147793225002897/vnrx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T09:55:38.904251+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}